(Q61854379)
Statements
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group (English)
0 references
1 March 2003
0 references
March 2003
0 references
14
0 references
3
0 references
441-448
0 references
441-8
0 references